PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Lifecore Biomedical Inc. (LFCR)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

Sector

Healthcare

IPO Date

Feb 15, 1996

Highlights

Market Cap

$222.15M

EPS (TTM)

-$0.56

PEG Ratio

3.51

Total Revenue (TTM)

$126.70M

Gross Profit (TTM)

$42.13M

EBITDA (TTM)

-$5.87M

Year Range

$3.68 - $8.45

Target Price

$8.50

Short %

10.82%

Short Ratio

7.52

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Lifecore Biomedical Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-40.00%-20.00%0.00%20.00%40.00%SeptemberOctoberNovemberDecember2025February
5.44%
9.51%
LFCR (Lifecore Biomedical Inc.)
Benchmark (^GSPC)

Returns By Period

Lifecore Biomedical Inc. had a return of -19.25% year-to-date (YTD) and -26.74% in the last 12 months. Over the past 10 years, Lifecore Biomedical Inc. had an annualized return of -8.25%, while the S&P 500 had an annualized return of 11.29%, indicating that Lifecore Biomedical Inc. did not perform as well as the benchmark.


LFCR

YTD

-19.25%

1M

-7.41%

6M

5.45%

1Y

-26.74%

5Y*

-12.47%

10Y*

-8.25%

^GSPC (Benchmark)

YTD

4.22%

1M

2.22%

6M

9.51%

1Y

22.46%

5Y*

12.74%

10Y*

11.29%

*Annualized

Monthly Returns

The table below presents the monthly returns of LFCR, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025-20.05%-19.25%
20245.49%27.87%-36.41%20.90%-9.03%-12.16%23.39%-30.81%12.56%15.21%30.46%0.27%20.03%
2023-4.17%-6.76%-34.72%12.43%92.71%18.07%8.17%-23.52%-5.62%-7.02%2.14%-13.67%-4.48%
2022-3.15%7.16%0.52%-14.08%-4.52%4.95%5.12%0.19%-15.33%11.92%-14.47%-23.85%-41.62%
2021-1.75%4.60%-4.93%6.79%5.74%-6.02%-2.76%-1.01%-14.87%5.42%-18.21%39.62%2.30%
2020-0.97%-8.39%-15.30%28.31%-4.30%-25.40%18.59%8.47%-5.08%-1.13%7.70%4.83%-4.07%
20197.18%1.18%-4.36%-14.41%-5.61%-5.54%19.21%-1.61%-1.09%-9.38%16.35%-1.31%-4.48%
20184.37%-1.14%0.38%1.92%6.02%5.67%-6.04%-3.93%7.06%-4.93%12.56%-23.17%-6.03%
2017-8.70%-0.00%-4.76%14.58%1.82%6.07%-17.17%5.69%-0.38%2.32%-5.66%0.80%-8.70%
20161.69%-16.13%4.06%7.14%2.93%-7.08%6.88%12.70%3.47%-1.19%7.92%-3.50%16.65%
2015-7.53%9.32%-0.07%1.86%0.56%0.98%-7.48%-0.37%-12.26%5.40%4.15%-7.65%-14.34%
2014-11.30%-5.21%9.52%6.27%1.26%4.00%-2.24%7.53%-6.70%2.78%4.37%5.10%13.94%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of LFCR is 30, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of LFCR is 3030
Overall Rank
The Sharpe Ratio Rank of LFCR is 2929
Sharpe Ratio Rank
The Sortino Ratio Rank of LFCR is 3434
Sortino Ratio Rank
The Omega Ratio Rank of LFCR is 3434
Omega Ratio Rank
The Calmar Ratio Rank of LFCR is 2828
Calmar Ratio Rank
The Martin Ratio Rank of LFCR is 2828
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Lifecore Biomedical Inc. (LFCR) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for LFCR, currently valued at -0.30, compared to the broader market-2.000.002.004.00-0.301.77
The chart of Sortino ratio for LFCR, currently valued at 0.11, compared to the broader market-6.00-4.00-2.000.002.004.006.000.112.39
The chart of Omega ratio for LFCR, currently valued at 1.02, compared to the broader market0.501.001.502.001.021.32
The chart of Calmar ratio for LFCR, currently valued at -0.29, compared to the broader market0.002.004.006.00-0.292.66
The chart of Martin ratio for LFCR, currently valued at -0.79, compared to the broader market0.0010.0020.0030.00-0.7910.85
LFCR
^GSPC

The current Lifecore Biomedical Inc. Sharpe ratio is -0.30. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Lifecore Biomedical Inc. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00SeptemberOctoberNovemberDecember2025February
-0.30
1.77
LFCR (Lifecore Biomedical Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


Lifecore Biomedical Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2025February
-71.08%
0
LFCR (Lifecore Biomedical Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Lifecore Biomedical Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Lifecore Biomedical Inc. was 92.05%, occurring on Sep 20, 2002. The portfolio has not yet recovered.

The current Lifecore Biomedical Inc. drawdown is 71.08%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-92.05%Jun 10, 19961582Sep 20, 2002
-11.76%Mar 27, 19968Apr 8, 19967Apr 17, 199615
-7.69%May 7, 19964May 10, 19963May 15, 19967
-4.82%Jun 6, 19961Jun 6, 19961Jun 7, 19962
-4.59%Feb 26, 19962Feb 27, 199610Mar 12, 199612

Volatility

Volatility Chart

The current Lifecore Biomedical Inc. volatility is 12.78%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%SeptemberOctoberNovemberDecember2025February
12.78%
3.19%
LFCR (Lifecore Biomedical Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Lifecore Biomedical Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Lifecore Biomedical Inc..


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab